X-ZELL enabling same-day diagnoses at German routine laboratory Budapest, October 2023 – New research has shown that X-ZELL Cryoimmunostaining™ is able to facilitate same-day cancer diagnoses from minimally invasive samples in routine clinical practice PD Dr. med....
X-ZELL technology used in development of new T cell therapy Singapore, September 2023 – A research team at Duke-NUS Medical School in Singapore has developed a T cell therapy that could play an important role in treating cancer recurrences after liver transplants. The...
First lab confirmed to introduce X-ZELL Cryoimmunostaining™ into clinical routine Frankfurt, June 2023 – X-ZELL, a pioneering company in the field of next-generation cytology, is proud to announce a strategic collaboration with the Medizinisches Versorgungszentrum für...
Former Roche Diagnostics NAM CEO Michael Tillmann joins X-ZELL executive board Singapore, August 2022 – X-ZELL is proud to announce the appointment of Michael Tillmann as member of the company’s executive board. Drawing on more than 30 years of experience in the...
X-ZELL appoints Sebastian Grote as Managing Director Singapore, March 2022 – Singaporean medical technology specialist X-ZELL has appointed Sebastian Grote as Managing Director, effective from 1 March 2022. Grote previously served as Head of Marketing & Strategy...
